The First Affiliated Hospital Of Chengdu Medical College

HSP60 Expression Levels Emerge as Critical Prognostic Marker in Ovarian Cancer Study

- A comprehensive study of 260 ovarian cancer patients reveals that high HSP60 expression correlates significantly with advanced disease stages, larger tumors, and increased lymph node metastasis. - Patients with elevated HSP60 levels demonstrated significantly shorter overall survival and disease-free survival rates, establishing HSP60 as an independent risk factor for poor prognosis. - The research identifies HSP60 as a potential therapeutic target, with 91.54% of cancerous tissues showing HSP60 staining compared to just 11.15% in normal tissues.